AstraZeneca teams up with West Coast AI company to develop new cancer drugs

The company's platform accelerates drug discovery by completing the cycle of data collection, AI-driven design, and wet-lab validation within an estimated six weeks.

Previous Durham biotech seeks partner to advance its gene therapy
Next Former Cerner exec steps into his second act leading Digital Health KC